Clinical Trials
8 trialsNCT07553767 2026-04-28
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Ningbo No.2 Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT02366286 2026-04-24
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT06786429 2026-01-21
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Eunice Dube
Phase 4 Not yet recruiting
NCT07253220 2025-11-28
TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma
Sun Yat-sen University
Phase NA Not yet recruiting
NCT06084234 2025-11-26
TRACER
University of Texas Southwestern Medical Center
Phase 4 Recruiting
NCT04525833 2025-09-19
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Recruiting
NCT07079150 2025-07-22
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
First Affiliated Hospital Xi'an Jiaotong University
Recruiting
NCT07038863 2025-06-26
Mondelta
Hospices Civils de Lyon
Phase NA Not yet recruiting